-
The neurological manifestations of chronic cirrhosis and hepatic failure are protean. Myoclonus (often negative), chorea, and dystonia may occur in these patients, often accompanied by pyramidal dysfunction and dementia.
-
Spinocerebellar ataxia type 3, Machado-Joseph disease (MJD), is an adult onset, autosomal-dominant disorder often presenting as a combination of upper and lower motor neuron signs, including facial and tongue fasciculations, resembling amyotrophic lateral sclerosis (ALS).
-
Surgical treatment for Parkinsons disease has become increasingly used as a modality of treatment. Nevertheless, the efficacy and its long-term outcomes as compared to medical therapy are not well established.
-
This article reports the novel observation that therapeutic vaccination with Copaxone (glatiramer acetate, Cop-1), protects motor neurons against acute and chronic neurodegenerative conditions.
-
Pneumococcal vaccine protects older adults from developing pneumococcal bacteremia but does not prevent community-acquired pneumonia (CAP), according to a new study from Group Health Cooperative in Seattle.
-
Intravenous immunoglobulin (IVIG) is an expensive but powerful and useful therapeutic tool in the neurologists armamentarium. Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Lambert-Eaton myasthenic syndrome, and dermatomyositis have all been shown, in controlled clinical trials, to benefit from IVIG.
-
Cerebral venous thrombosis (CVT) is a stroke syndrome characterized by headache, seizures, and hemorrhagic infarction.
-
A new oral direct thrombin inhibitorximelagatran (Exanata; Astra-Zeneca)steals the stage at this years American College of Cardiology 52nd Scientific Session in Chicago.
-
Pneumococcal vaccine protects older adults from developing pneumococcal bacteremia but does not prevent community-acquired pneumonia (CAP), according to a new study from Group Health Cooperative in Seattle.
-
It is possible to use pacemakers to detect symptomatic and asymptomatic nonsustained atrial high-rate episodes, and detection of these atrial high-rate episodes identifies patients at higher risk for death, stroke, and atrial fibrillation.